{"filing":{"accession_number":"0001171520-26-000313","cik":"0001807689","ticker":"FCCI","company_name":"Eyeonix AIQ, Inc.","form":"8-K","filing_date":"2026-10-22","report_date":"2026-10-16","primary_document":"eps12899_eaiq.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1807689/000117152026000313/eps12899_eaiq.htm"},"events":[{"id":37161,"run_id":34260,"accession_number":"0001171520-26-000313","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of two directors, Dr. Rohit Chitale and Dr. Grigoris Gerotziafas, to the board of directors effective immediately following an Extraordinary Meeting on October 16, 2026. This is a clear executive appointment event under Item 5.02, and board composition changes are material to investors' assessment of governance and strategic direction.","company_name":"Eyeonix AIQ, Inc.","ticker":"FCCI","filing_date":"2026-10-22","form":"8-K","submitted_at":null,"items":[{"id":41775,"accession_number":"0001171520-26-000313","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of two directors, Dr. Rohit Chitale and Dr. Grigoris Gerotziafas, to the board of directors effective immediately following an Extraordinary Meeting on October 16, 2026. This is a clear executive appointment event under Item 5.02, and board composition changes are material to investors' assessment of governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T18:32:36.229330+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41775,"accession_number":"0001171520-26-000313","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors;","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of two directors, Dr. Rohit Chitale and Dr. Grigoris Gerotziafas, to the board of directors effective immediately following an Extraordinary Meeting on October 16, 2026. This is a clear executive appointment event under Item 5.02, and board composition changes are material to investors' assessment of governance and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-22T18:32:36.229330+00:00","company_name":"Eyeonix AIQ, Inc.","ticker":"FCCI","filing_date":"2026-10-22"}]}